Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
USFDA okays Mylan, Biocon's biosimilar of cancer drug Herceptin

Ogivri is the first United States Food and Drug Administration (USFDA) approved biosimilar to Herceptin and the first biosimilar from Mylan and Biocon's joint portfolio approved in the US, the two companies said in a joint statement.

Advertisement